epilepsy
UniQure to Start Clinical Trial for Epilepsy Gene Therapy This Year
The FDA cleared the company's IND for AMT-260, a gene therapy designed to treat refractory mesial temporal lobe epilepsy by suppressing GLUK2 expression.
Epilepsy Management Often Shifts After Multigene Panel Testing, Study Finds
Researchers tracked treatment and outcome changes in a retrospective analysis of epilepsy patients with pathogenic or likely pathogenic variants found by multigene panel testing.